Rubicon Genomics is a privately held company located in Ann Arbor, Michigan. Our products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development.
Our partnerships with the academic community and our customers have fueled our engine, resulting in a robust pipeline of future products. Our products break the sample barriers for our customers allowing use of less sample from a diverse set of sample sources. Each of our kits is constructed for ease of use, accuracy, and speed to results. RGI products can be purchased direct, through our distributors or OEM partners.
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medical applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy.
Rubicon Genomics develops innovative, high quality, nucleic acid library preparation and companion products that enable easy, reliable, and highly sensitive analysis of clinical research samples. Rubicon is committed to teamwork and continuous improvement to provide excellence to our customers, shareholders, and employees.